Aspirin for the Prevention of Preeclampsia and Pregnancy Outcomes After Assisted Reproductive Technology
Status:
Not yet recruiting
Trial end date:
2026-05-01
Target enrollment:
Participant gender:
Summary
This study seeks to validate the hypothesis that nulliparous pregnant women after Assisted
Reproductive Technology (ART) are at high risk of preeclampsia and perinatal complications
and represent a subgroup for which aspirin prophylaxis during pregnancy may be effective in
the prevention of preterm preeclampsia and other perinatal adverse outcomes.